Economic benefit of a centralized reconstitution unit of cytotoxic drugs in isolator
M Favier, E Fliche, F Bressolle - Journal of Oncology …, 1996 - journals.sagepub.com
Introduction. A cytotoxic drug reconstitution sys tem generates a saving in drugs due to a
reduction in drug wastage by reusing partly used vials. We con ducted a study at a 1900-bed …
reduction in drug wastage by reusing partly used vials. We con ducted a study at a 1900-bed …
Clinical relevance of routine monitoring of patient-reported outcomes versus clinician-reported outcomes in oncology
F Fiteni, A Cuenant, M Favier, C Cousin, N Houédé - in vivo, 2019 - iv.iiarjournals.org
The National Cancer Institute Common Terminology Criteria for Adverse Events classification
is the standard classification used by the physicians in oncology for reporting adverse …
is the standard classification used by the physicians in oncology for reporting adverse …
Standardized order form for investigational drugs: effect on completeness of the prescription
V Ollivier, C Thelcide, C Simon, M Favier - Pharmacy World and Science, 2004 - Springer
Aim: To compare completeness and quality of orders written before and after introduction of
a preprinted medication order form for investigational drugs. Completeness of physician's …
a preprinted medication order form for investigational drugs. Completeness of physician's …
Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers
…, C Maillard, JM Kinowski, M Favier - American journal of …, 2005 - academic.oup.com
Purpose. The compatibility of ondansetron hydrochloride and methylprednisolone sodium
succinate in 5% dextrose injection and 0.9% sodium chloride injection was studied. Methods. …
succinate in 5% dextrose injection and 0.9% sodium chloride injection was studied. Methods. …
Preparing cytotoxic agents in an isolator
M Favier, S Hansel, F Bressolle - American Journal of Hospital …, 1993 - academic.oup.com
The design of an isolator and its use by an oncology satellite pharmacy for preparing cytotoxic
drugs are described. The isolator (Iso Concept, Boulogne, France) is a totally enclosed …
drugs are described. The isolator (Iso Concept, Boulogne, France) is a totally enclosed …
Chimiothérapies dans le cancer colorectal: étude pragmatique des modifications de prescription et de dose intensité
…, V Phouttasang, P Wolf, S Bastide, C Cousin, M Favier - Bulletin du …, 2017 - Elsevier
Introduction Les toxicités induites par les chimiothérapies peuvent générer des modifications
de prescription et de dose intensité relative, ayant un impact sur l’efficacité thérapeutique. …
de prescription et de dose intensité relative, ayant un impact sur l’efficacité thérapeutique. …
Chemotherapy for colorectal cancer: Pragmatic assessment of prescription changes and relative dose intensity
…, P Wolf, S Bastide, C Cousin, M Favier - Bulletin du …, 2017 - europepmc.org
Method This is a prospective observational study performed in hepato-gastroenterology
department for 6 months. All patients treated for colorectal cancer and beginning a protocol with …
department for 6 months. All patients treated for colorectal cancer and beginning a protocol with …
Medico-economic benefits of subcutaneous formulations of trastuzumab and rituximab in day hospitalisation (SCuBA Study)
M Favier, I Vincent-Cantini, V Launay, EA Giroux… - Bulletin du …, 2018 - europepmc.org
Methods Thirty-six day care units in 30 hospitals or clinics participated in this observational
study. Data were collected on the capacity of the units, the number of chemotherapy sessions …
study. Data were collected on the capacity of the units, the number of chemotherapy sessions …
Élaboration d'un guide standardisé d'informations d'optimisation de l'adhésion médicamenteuse à dispenser lors d'une consultation pharmaceutique au patient atteint …
C Favier-Archinard, G Leguelinel-Blache, C Cousin… - Bulletin du …, 2018 - Elsevier
Une validation initiale d’un guide de consultation pharmaceutique standardisé a été
réalisée dans un précédent travail pour optimiser l’adhésion médicamenteuse du patient au …
réalisée dans un précédent travail pour optimiser l’adhésion médicamenteuse du patient au …
Bénéfices médicoéconomiques des formes sous-cutanées de trastuzumab et de rituximab en hospitalisation de jour (étude SCuBA)
M Favier, F Le Goc-Sager, I Vincent-Cantini, V Launay… - Bulletin du …, 2018 - Elsevier
Introduction De nouvelles formes galéniques de trastuzumab et rituximab ont été
développées pour administration par voie sous-cutanée, permettant ainsi des protocoles d’…
développées pour administration par voie sous-cutanée, permettant ainsi des protocoles d’…